75F40125C00095↗

Name: 75F40125C00095: Baa# Fy25C3Ap3 - (H20) a Next Generation Medical Countermeasures Scientific Platform for Regulatory Evaluation and Preparedness
Creator: SpendQuery
License: https://www.usa.gov/government-works

Dna Hive LLC received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $7.46M obligated so far for health r&d services; health care services; basic research. It runs to 2028-09-29.

Key facts · data as of Oct 22, 2026

Recipient: Dna Hive LLC
Awarding agency: Food and Drug Administration (Department of Health and Human Services)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Obligated to date: $7.46M
Potential value: $7.46M
Ends: 2028-09-29

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.

Cite this page: SpendQuery, Award 75F40125C00095, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_75F40125C00095_7524_-NONE-_-NONE-

Dna Hive LLC: all federal awards · Department of Health and Human Services: spending · Fda Office of Acq Grant Svcs: what it buys · The follow-on: recompete brief

BAA# FY25C3AP3 - (H20) A NEXT GENERATION MEDICAL COUNTERMEASURES SCIENTIFIC PLATFORM FOR REGULATORY EVALUATION AND PREPAREDNESS

Definitive Contract · Food and Drug Administration · to Dna Hive LLC (UEI ZULRXE8XYEM3) · data as of 2026-10-22

Obligated to date$7.46M2 actions

Current value$7.46Mwith options exercised

Period2025-09-23 → 2028-09-29current end date

Up for re-bid: ends 2028-09-29. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office: Fda Office of Acq Grant Svcs (75F401)
Competition: Full and open competition · 1 offer received
Pricing: Cost no fee
How it was bought: Standalone contract
Solicitation: FDABAA-25-00123
Where the work is: Montgomery, MD · district MD-08

Obligations by fiscal year

FY2025$3.09M

FY2026$4.37M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2025-09-23. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-24	P00001	Supplemental agreement (work within scope)	$4.37M	BAA# FY25C3AP3 - HIVE 2.0: EXPANSION OF FDA ARGOS
2025-09-23	0		$3.09M	BAA# FY25C3AP3 - (H20) A NEXT GENERATION MEDICAL COUNTERMEASURES SCIENTIFIC PLATFORM FOR REGULATORY EVALUATION AND PREPAREDNESS

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…